The purpose of this standard operating procedure is to outline a step-by-step approach for undertaking active drug safety monitoring for the 9-month MDR-TB treatment regimen and other novel medications and regimens for TB and MDR-TB.
This document outlines the strategic approach, planned activities, technical resources, program management, monitoring and evaluation, and budget and funding for the Philippines Work Plan from October 2012-September 2013.
The Philippines is one of the 22 countries worldwide with the highest tuberculosis (TB) rates and one of the 27 highest multidrug resistant tuberculosis (MDR-TB) burden countries. In late 2011, Quezon City Health Department (QCHD), with the support of the US Agency for International Development (USAID)-funded Systems for Improving Access to Pharmaceuticals and Services (SIAPS) Program, took … Read more
Despite an increase in access to medicines in low- and middle-income countries (LMICs), fully functional pharmacovigilance and regulatory systems are not yet in place. Strengthening regulatory and pharmacovigilance systems is a global imperative for preventing harm and improving outcomes in treatment and prevention programs. The Asia region both supplies and purchases medical products. A better … Read more
